Business Context and Reporting Period
This Form 8-K Current Report is filed by Overstock.com, Inc. (not Bed Bath & Beyond, Inc., as indicated in the metadata request) on August 9, 2018. The filing discloses the entry into two material definitive agreements with JonesTrading Institutional Services LLC to facilitate the sale of the Company's common stock.
Key Financial Metrics and Agreements
The filing details two distinct capital raising mechanisms rather than operational financial results (revenue, profit, or cash flow) for a specific period:
- Capital on Demand Sales Agreement: Authorization to sell up to $150 million of common stock via "at-the-market" offerings.
- Standby Equity Underwriting Agreement: Option to sell up to $50 million of common stock to JonesTrading in tranches of up to $5 million.
- Commission Fees: Up to 2.0% of gross sales price under the Sales Agreement.
- Commitment Fee: A fixed fee of $500,000 paid or payable for the Standby Underwriting Agreement.
- Expense Reimbursement: Up to $10,000 for legal and specified expenses under the Sales Agreement.
Material Changes and Terms
The primary material change is the establishment of new financing facilities. Key terms include:
- Pricing Mechanism: Under the Standby Underwriting Agreement, the sale price is set at 97% of the average daily volume-weighted average price (VWAP) for the two trading days following the sale notice.
- Over-Allotment Option: JonesTrading holds an option to purchase an additional 15% of shares in any tranche sold under the Standby Underwriting Agreement.
- Interaction of Agreements: The $50 million capacity under the Standby Underwriting Agreement is reduced dollar-for-dollar by any sales made under the $150 million Sales Agreement or other registered offerings.
- Termination: The Standby Underwriting Agreement may be terminated by the Company at any time after 90 days, or by JonesTrading if the stock is no longer actively traded.
Guidance, Risks, and Contingencies
The filing contains forward-looking statements regarding future capital raising activities. Key risks and contingencies include:
- No Obligation to Sell: The Company is not obligated to sell any shares under the Sales Agreement, and there is no assurance of the price or volume of shares sold.
- Dilution: The sale of shares under these agreements will result in dilution to existing shareholders.
- Market Conditions: The ability to sell shares is subject to market conditions and the Company's discretion regarding pricing floors.
- Related Party Transactions: The CEO and High Plains Investments LLC may utilize JonesTrading as a broker for Rule 144 sales, though the Company states it has no other material relationship with JonesTrading.
Investor Verification Checklist
- Verify the current share count and potential dilution impact of a full $200 million issuance ($150M ATM + $50M Standby).
- Review the full text of the Sales Agreement (Exhibit 10.1) and Standby Underwriting Agreement (Exhibit 10.2) for specific termination clauses and pricing adjustments.
- Monitor subsequent filings (e.g., Form 4 or 8-K) to track actual sales volumes and proceeds generated under these agreements.
- Confirm the Company's current cash position and liquidity needs to understand the urgency of utilizing these facilities.